JMP Securities Increases Option Care Health (NASDAQ:OPCH) Price Target to $37.00

Option Care Health (NASDAQ:OPCH) had its price objective upped by research analysts at JMP Securities from $36.00 to $37.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “market outperform” rating on the stock. JMP Securities’ price objective would indicate a potential upside of 18.89% from the company’s current price.

Separately, Barrington Research upped their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a research note on Thursday, August 1st.

Option Care Health Price Performance

Shares of Option Care Health stock traded down $0.30 on Monday, hitting $31.12. 54,106 shares of the company traded hands, compared to its average volume of 1,385,923. Option Care Health has a 12-month low of $26.11 and a 12-month high of $34.63. The company has a current ratio of 1.76, a quick ratio of 1.36 and a debt-to-equity ratio of 0.78. The company has a market cap of $5.41 billion, a P/E ratio of 20.47, a P/E/G ratio of 2.42 and a beta of 1.29. The firm’s 50-day simple moving average is $31.29 and its 200 day simple moving average is $30.40.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.03. The business had revenue of $1.23 billion for the quarter, compared to the consensus estimate of $1.17 billion. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The company’s revenue for the quarter was up 14.8% on a year-over-year basis. During the same quarter last year, the business posted $0.63 earnings per share. Analysts expect that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Several institutional investors and hedge funds have recently bought and sold shares of OPCH. Parallel Advisors LLC grew its position in shares of Option Care Health by 130.2% in the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock worth $28,000 after buying an additional 478 shares during the period. TFO Wealth Partners LLC increased its stake in shares of Option Care Health by 24,625.0% during the fourth quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock valued at $33,000 after purchasing an additional 985 shares in the last quarter. Park Place Capital Corp lifted its holdings in shares of Option Care Health by 48.4% during the first quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock valued at $38,000 after purchasing an additional 372 shares during the last quarter. SageView Advisory Group LLC bought a new stake in shares of Option Care Health in the 1st quarter worth approximately $85,000. Finally, Blue Trust Inc. grew its stake in shares of Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after buying an additional 377 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.